Fastest Growing Canadian Companies by Revenue — Health Care
Canadian companies ranked by year-over-year revenue growth.
Showing 200 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | Revenue (TTM) | Revenue Growth (YoY) |
|---|---|---|---|---|---|
| 1 | Axe Compute Inc. | AGPU:US | $89M | $3M | 119772.90% |
| 2 | Precision BioSciences Inc | DTIL:US | $363M | $45M | 37272.40% |
| 3 | 4D Molecular Therapeutics Inc | FDMT:US | $689M | $92M | 25106.70% |
| 4 | Vir Biotechnology Inc | VIR:US | $2.2B | $303M | 19582.50% |
| 5 | Freenome, Inc. Common stock | FRNM:US | $1.2B | $218M | 17628.40% |
| 6 | Nakamoto Inc. | NAKA:US | $104M | $28M | 8680.10% |
| 7 | MeiraGTx Holdings PLC | MGTX:US | $924M | $398M | 8608.60% |
| 8 | Nurix Therapeutics Inc | NRIX:US | $1.8B | $702M | 8426.30% |
| 9 | Adagene Inc | ADAG:US | $142M | $9M | 7332.80% |
| 10 | Solana Company | HSDT:US | $125M | $12M | 5774.40% |
| 11 | Protagonist Therapeutics Inc | PTGX:US | $8.9B | $552M | 5723.60% |
| 12 | Connect Biopharma Holdings Ltd | CNTB:US | $47M | $3M | 5666.70% |
| 13 | NewAmsterdam Pharma Company N.V. Ordinary Shares | NAMS:US | $2.4B | $26M | 5406.90% |
| 14 | Alector Inc | ALEC:US | $366M | $173M | 4895.90% |
| 15 | Aethlon Medical Inc | AEMD:US | $9M | $574,245 | 4278.20% |
| 16 | Therma Bright Inc | THRM:V | $2M | $135,824 | 3771.40% |
| 17 | Aligos Therapeutics Inc | ALGS:US | $25M | $32M | 2778.50% |
| 18 | Abeona Therapeutics Inc | ABEO:US | $142M | $39M | 2745.00% |
| 19 | Precigen Inc | PGEN:US | $1.6B | $157M | 2437.60% |
| 20 | Cytokinetics Inc | CYTK:US | $8.2B | $113M | 2356.50% |
| 21 | Roivant Sciences Ltd | ROIV:US | $29.4B | $41M | 2135.60% |
| 22 | HCW Biologics Inc | HCWB:US | $2M | $7M | 1969.70% |
| 23 | Liquidia Technologies Inc | LQDA:US | $4.6B | $451M | 1842.70% |
| 24 | Hyperion DeFi, Inc. | HYPD:US | $39M | $1M | 1559.50% |
| 25 | Pasithea Therapeutics Corp | KTTA:US | $18M | $486,559 | 1498.10% |
| 26 | Praxis Precision Medicines Inc | PRAX:US | $9.3B | $7M | 1349.10% |
| 27 | Crispr Therapeutics AG | CRSP:US | $4.4B | $25M | 1325.10% |
| 28 | AC Immune Ltd | ACIU:US | $243M | $18M | 1057.20% |
| 29 | Moolec Science SA Ordinary Shares | MLEC:US | $1M | $8M | 948.30% |
| 30 | Exicure Inc | XCUR:US | $7M | - | 928.00% |
| 31 | Foghorn Therapeutics Inc | FHTX:US | $125M | $112M | 924.70% |
| 32 | Rani Therapeutics Holdings Inc | RANI:US | $81M | $5M | 893.00% |
| 33 | Zymeworks Inc. Common Stock | ZYME:US | $2.2B | $266M | 828.70% |
| 34 | KDA Group Inc | KDA:V | $12M | $419,129 | 791.20% |
| 35 | Bio Green Med Solution, Inc. | BGMS:US | $4M | $2M | 710.00% |
| 36 | Virax Biolabs Group Limited Ordinary Shares | VRAX:US | $1M | $12,423 | 684.90% |
| 37 | Immutep Ltd ADR | IMMP:US | $27M | $20M | 633.50% |
| 38 | Bullfrog AI Holdings, Inc. Common Stock | BFRG:US | $11M | $298,798 | 547.60% |
| 39 | VistaGen Therapeutics Inc | VTGN:US | $8M | $3M | 504.90% |
| 40 | Dare Bioscience Inc | DARE:US | $14M | $1M | 499.60% |
| 41 | Kymera Therapeutics Inc | KYMR:US | $11.7B | $102M | 466.40% |
| 42 | Xencor Inc | XNCR:US | $2.9B | $200M | 454.90% |
| 43 | PAVmed Inc | PAVM:US | $13M | $112,000 | 450.00% |
| 44 | Scienture Holdings, Inc. | SCNX:US | $5M | $821,315 | 449.10% |
| 45 | Tonix Pharmaceuticals Holding Corp | TNXP:US | $80M | $43M | 423.80% |
| 46 | Hydreight Technologies Inc | NURS:V | $163M | $78M | 421.40% |
| 47 | Altimmune Inc | ALT:US | $412M | $31,000 | 420.00% |
| 48 | Surrozen Inc | SRZN:US | $560M | $11M | 408.60% |
| 49 | Mesoblast Ltd | MESO:US | $1.8B | $120M | 390.70% |
| 50 | Apollomics Inc. Class A Ordinary Shares | APLM:US | $54M | $9M | 380.80% |
| 51 | MacroGenics Inc | MGNX:US | $154M | $175M | 378.00% |
| 52 | Nyxoah | NYXH:US | $91M | $29M | 365.00% |
| 53 | Pulse Biosciences Inc | PLSE:US | $4.1B | $1M | 359.30% |
| 54 | Pharmacielo Ltd | PCLO:V | $10M | $4M | 331.00% |
| 55 | Agios Pharm | AGIO:US | $1.9B | $141M | 330.00% |
| 56 | Monte Rosa Therapeutics Inc | GLUE:US | $904M | $70M | 325.80% |
| 57 | YD Bio Ltd | YDES:US | $475M | $1M | 314.90% |
| 58 | Kazia Therapeutics Ltd ADR | KZIA:US | $85M | $2M | 312.40% |
| 59 | MedMira Inc | MIR:V | $39M | $370,568 | 308.00% |
| 60 | Sinovac Biotech Ltd | SVA:US | $642M | $511M | 303.70% |
| 61 | Atea Pharmaceuticals Inc | AVIR:US | $354M | $192M | 295.20% |
| 62 | Insmed Inc | INSM:US | $26.2B | $1.5B | 268.40% |
| 63 | Alpha Cognition Inc | ACOG:US | $190M | $15M | 267.60% |
| 64 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | CUPR:US | $13M | $49,894 | 267.40% |
| 65 | Recursion Pharmaceuticals Inc | RXRX:US | $2.2B | $68M | 258.50% |
| 66 | INmune Bio Inc | INMB:US | $34M | - | 257.10% |
| 67 | MediciNova Inc | MNOV:US | $72M | $920,481 | 240.60% |
| 68 | Clene Inc. | CLNN:US | $63M | $197,000 | 233.30% |
| 69 | UroGen Pharma Ltd | URGN:US | $1.3B | $250M | 223.90% |
| 70 | Dianthus Therapeutics Inc. | DNTH:US | $5.0B | $3M | 205.60% |
| 71 | SINTX Technologies Inc | SINT:US | $12M | $1M | 199.30% |
| 72 | Silence Therapeutics PLC | SLN:US | $1.2B | $615,000 | 197.20% |
| 73 | BridgeBio Pharma Inc | BBIO:US | $15.5B | $946M | 192.60% |
| 74 | Bicycle Therapeutics Ltd | BCYC:US | $259M | $84M | 190.20% |
| 75 | Keros Therapeutics Inc | KROS:US | $187M | $41M | 180.50% |
| 76 | Adlai Nortye Ltd. American Depositary Shares | ANL:US | $699M | $18M | 178.10% |
| 77 | Taysha Gene Therapies Inc | TSHA:US | $1.4B | $5M | 171.30% |
| 78 | Arrowhead Pharmaceuticals Inc | ARWR:US | $6.9B | $669M | 171.00% |
| 79 | Avricore Health Inc | AVCR:V | $6M | $193,041 | 170.40% |
| 80 | Cue Biopharma | CUE:US | $136M | $38M | 166.70% |
| 81 | Healthcare Triangle Inc | HCTI:US | $4M | $26M | 158.40% |
| 82 | Eton Pharmaceuticals Inc | ETON:US | $1.9B | $141M | 157.90% |
| 83 | CorMedix Inc | CRMD:US | $427M | $462M | 156.50% |
| 84 | Senseonics Holdings, Inc. Common Stock | SENS:US | $530M | $60M | 141.60% |
| 85 | CAMP4 THERAPEUTICS CORPORATION | CAMP:US | $264M | $5M | 138.90% |
| 86 | ATAI Life Sciences BV | ATAI:US | $2.7B | $4M | 137.00% |
| 87 | Xilio Development Inc | XLO:US | $56M | $64M | 131.20% |
| 88 | Tenon Medical Inc | TNON:US | $5M | $5M | 126.80% |
| 89 | ProQR Therapeutics BV | PRQR:US | $185M | $18M | 120.40% |
| 90 | Autolus Therapeutics Ltd | AUTL:US | $351M | $117M | 118.40% |
| 91 | RenovoRx Inc | RNXT:US | $57M | $2M | 115.40% |
| 92 | Ascendis Pharma AS | ASND:US | $17.1B | $1.0B | 114.70% |
| 93 | Verastem Inc | VSTM:US | $1.1B | $100M | 113.60% |
| 94 | Aktis Oncology, Inc. Common stock | AKTS:US | $910M | $10M | 111.40% |
| 95 | Compugen | CGEN:US | $198M | $74M | 107.00% |
| 96 | ABVC Biopharma Inc | ABVC:US | $27M | $797,916 | 104.50% |
| 97 | LSL Pharma Group Inc. | LSL:V | $36M | $42M | 102.70% |
| 98 | Biosyent Inc. | RX:V | $201M | $56M | 95.20% |
| 99 | Immatics NV | IMTX:US | $977M | $42M | 93.00% |
| 100 | Reliq Health Technologies Inc | RHT:V | $47M | $15M | 88.50% |
| 101 | OneMedNet Corp. | ONMD:US | $34M | $1M | 88.40% |
| 102 | Fennec Pharmaceuticals Inc | FENC:US | $380M | $59M | 85.20% |
| 103 | Fennec Pharmaceuticals Inc | FRX:TO | $466M | $59M | 85.20% |
| 104 | SeaStar Medical Holding Corporation | ICU:US | $6M | $2M | 82.00% |
| 105 | Syndax Pharmaceuticals Inc | SNDX:US | $854M | $290M | 81.60% |
| 106 | Numinus Wellness Inc | NUMI:TO | $16M | $6M | 81.60% |
| 107 | Iovance Biotherapeutics Inc | IOVA:US | $3.7B | $379M | 80.10% |
| 108 | Rhythm Pharmaceuticals Inc | RYTM:US | $7.9B | $281M | 79.60% |
| 109 | OmniAb Inc. | OABI:US | $722M | $40M | 78.30% |
| 110 | Aclarion Inc | ACON:US | $5M | $98,560 | 78.10% |
| 111 | Personalis Inc | PSNL:US | $1.7B | $81M | 76.60% |
| 112 | Sera Prognostics Inc | SERA:US | $79M | $70,000 | 76.50% |
| 113 | Adagio Medical Holdings, Inc Common Stock | ADGM:US | $50M | $137,000 | 75.60% |
| 114 | Cronos Group Inc | CRON:US | $1.2B | $206M | 74.60% |
| 115 | Cronos Group Inc | CRON:TO | $1.8B | $206M | 74.60% |
| 116 | Anbio Biotechnology Class A Ordinary Shares | NNNN:US | $179M | $9M | 73.90% |
| 117 | Hyperfine Inc | HYPR:US | $75M | $19M | 73.40% |
| 118 | Wave Life Sciences Ltd | WVE:US | $686M | $71M | 73.00% |
| 119 | Icecure Medical | ICCM:US | $3M | $4M | 72.80% |
| 120 | Phathom Pharmaceuticals Inc | PHAT:US | $433M | $275M | 71.10% |
| 121 | Delcath Systems Inc | DCTH:US | $697M | $110M | 70.70% |
| 122 | TG Therapeutics Inc | TGTX:US | $9.7B | $800M | 70.30% |
| 123 | BGM Group Ltd. | BGM:US | $115M | $48M | 69.80% |
| 124 | Aequus Pharmaceuticals Inc | AQS:V | $1M | $918,468 | 69.70% |
| 125 | PTC Therapeutics Inc | PTCT:US | $5.4B | $1.2B | 69.60% |
| 126 | Alamar Biosciences, Inc. Common Stock | ALMR:US | $2.2B | $114M | 68.50% |
| 127 | Capstone Holding Corp. Common Stock | CAPS:US | $2M | $60M | 67.10% |
| 128 | Corcept Therapeutics Incorporated | CORT:US | $8.0B | $964M | 64.00% |
| 129 | Tarsus Pharmaceuticals Inc | TARS:US | $3.6B | $682M | 63.90% |
| 130 | Anteris Technologies Global Corp. Common Stock | AVR:US | $573M | $2M | 63.30% |
| 131 | X4 Pharmaceuticals Inc | XFOR:US | $331M | $17M | 63.10% |
| 132 | Basel Medical Group Ltd Ordinary Shares | BMGL:US | $73M | $22M | 63.00% |
| 133 | VentriPoint Diagnostics Ltd | VPT:V | $13M | $147,773 | 61.70% |
| 134 | Kestra Medical Technologies, Ltd. Common Stock | KMTS:US | $1.8B | $107M | 59.90% |
| 135 | Sonoma Pharmaceuticals Inc | SNOA:US | $5M | $22M | 59.60% |
| 136 | Crescita Therapeutics Inc | CTX:TO | $15M | $23M | 59.40% |
| 137 | Redhill Biopharma Ltd | RDHL:US | $3M | - | 58.60% |
| 138 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $7.5B | $946M | 58.10% |
| 139 | Carlsmed, Inc. | CARL:US | $438M | $63M | 56.70% |
| 140 | Ionis Pharmaceuticals Inc | IONS:US | $5.2B | $960M | 54.90% |
| 141 | Star Equity Holdings Prf | STRRP:US | - | $210M | 54.60% |
| 142 | Star Equity Holdings Inc | STRR:US | $34M | $210M | 54.60% |
| 143 | Clover Health Investments Corp | CLOV:US | $2.7B | $2.7B | 53.10% |
| 144 | Avita Medical Ltd | RCEL:US | $555M | $85M | 53.10% |
| 145 | Carespan Health Inc | CSPN:V | $1M | $-145,310 | 53.10% |
| 146 | Immunitybio Inc | IBRX:US | $7.5B | $183M | 52.30% |
| 147 | argenx NV ADR | ARGX:US | $60.5B | $5.9B | 52.10% |
| 148 | Pulsenmore Ltd. Ordinary Shares | PLSM:US | $10M | - | 52.00% |
| 149 | Axsome Therapeutics Inc | AXSM:US | $7.9B | $865M | 51.90% |
| 150 | Innovative Eyewear Inc. | LUCY:US | $7M | $4M | 51.10% |
| 151 | Madrigal Pharmaceuticals Inc | MDGL:US | $10.1B | $1.4B | 50.10% |
| 152 | iTonic Holdings Ltd. | ITOC:US | $14M | $556,430 | 49.50% |
| 153 | OrganiGram Holdings Inc | OGI:US | $126M | $309M | 49.40% |
| 154 | OrganiGram Holdings Inc | OGI:TO | $174M | $309M | 49.40% |
| 155 | Gelteq Limited Ordinary Shares | GELS:US | $4M | $471,799 | 48.90% |
| 156 | Heartflow, Inc. Common Stock | HTFL:US | $4.9B | $212M | 47.60% |
| 157 | BillionToOne, Inc. Class A Common Stock | BLLN:US | $5.3B | $437M | 47.20% |
| 158 | Arcutis Biotherapeutics Inc | ARQT:US | $3.3B | $509M | 45.10% |
| 159 | Zevra Therapeutics Inc. | ZVRA:US | $664M | $148M | 44.90% |
| 160 | Xeris Pharmaceuticals Inc | XERS:US | $3.0B | $368M | 44.20% |
| 161 | Extendicare Inc | EXE:TO | $2.7B | $2.2B | 42.60% |
| 162 | Precision Optics Corporation, Inc. Common stock | POCI:US | $56M | $32M | 42.00% |
| 163 | Neurocrine Biosciences Inc | NBIX:US | $17.7B | $3.7B | 41.20% |
| 164 | TransMedics Group Inc | TMDX:US | $3.2B | $728M | 41.10% |
| 165 | Prelude Therapeutics Inc | PRLD:US | $300M | $22M | 41.00% |
| 166 | Uniqure NV | QURE:US | $1.6B | $20M | 40.40% |
| 167 | Mirum Pharmaceuticals Inc | MIRM:US | $6.2B | $671M | 39.60% |
| 168 | SS Innovations International Inc. Common Stock | SSII:US | $303M | $52M | 39.40% |
| 169 | CareDx Inc | CDNA:US | $4.4B | $497M | 39.30% |
| 170 | Halozyme Therapeutics Inc | HALO:US | $11.6B | $1.8B | 39.20% |
| 171 | Assembly Biosciences Inc | ASMB:US | $435M | $75M | 38.90% |
| 172 | Harrow Health Inc | HROW:US | $1.1B | $303M | 38.60% |
| 173 | Editas Medicine Inc | EDIT:US | $385M | $50M | 37.40% |
| 174 | Nano X Imaging Ltd | NNOX:US | $18M | $16M | 36.70% |
| 175 | Alignment Healthcare LLC | ALHC:US | $1.5B | $4.9B | 36.70% |
| 176 | Kura Oncology Inc | KURA:US | $673M | $77M | 36.50% |
| 177 | 20/20 Biolabs, Inc. Common Stock | AIDX:US | $3M | $2M | 36.50% |
| 178 | Kyntra Bio, Inc. | KYNB:US | $15M | $5M | 36.50% |
| 179 | Regeneron Pharmaceuticals Inc | REGN:US | $95.2B | $16.9B | 36.30% |
| 180 | Clearpoint Neuro Inc | CLPT:US | $294M | $45M | 36.30% |
| 181 | Travere Therapeutics Inc | TVTX:US | $5.0B | $651M | 36.20% |
| 182 | Guardant Health Inc | GH:US | $21.0B | $1.3B | 36.10% |
| 183 | Intelligent Bio Solutions Inc. | INBS:US | $7M | $4M | 35.80% |
| 184 | Brainsway Ltd | BWAY:US | $469M | $61M | 35.40% |
| 185 | Vivos Therapeutics Inc | VVOS:US | $3M | $21M | 34.90% |
| 186 | Humacyte Inc | HUMA:US | $164M | $2M | 34.90% |
| 187 | Omada Health, Inc. Common Stock | OMDA:US | $934M | $333M | 34.20% |
| 188 | Natera Inc | NTRA:US | $46.4B | $2.9B | 34.10% |
| 189 | Establishment Labs Holdings Inc | ESTA:US | $2.0B | $264M | 33.90% |
| 190 | BeOne Medicines AG | ONC:US | $48.4B | $6.6B | 33.80% |
| 191 | MedX Health Corp | MDX:V | $15M | $569,792 | 33.70% |
| 192 | Vitalhub Corp | VHI:TO | $509M | $127M | 33.00% |
| 193 | Biofrontera Inc | BFRI:US | $14M | $46M | 32.90% |
| 194 | Voyageur Pharmaceuticals Ltd | VM:V | $31M | $50,854 | 32.70% |
| 195 | Quipt Home Medical Corp. | QIPT:TO | $221M | $265M | 32.00% |
| 196 | Biomarin Pharmaceutical Inc | BMRN:US | $11.1B | $3.7B | 32.00% |
| 197 | Pennant Group Inc | PNTG:US | $1.3B | $1.2B | 32.00% |
| 198 | Legend Biotech Corp | LEGN:US | $3.8B | $1.4B | 32.00% |
| 199 | Universal Ibogaine Inc | IBO:V | $2M | $2M | 30.60% |
| 200 | Beta Bionics, Inc. Common Stock | BBNX:US | $968M | $127M | 30.30% |
Frequently Asked Questions
Which Canadian company ranks #1 by revenue growth (yoy) in Health Care?
As of November 15, 2026, Axe Compute Inc. (AGPU:US) ranks #1 in Health Care at 119772.90%.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of November 15, 2026.
How many companies are in this revenue growth (yoy) list?
This view shows 200 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Largest by Revenue
Companies with the highest annual revenue
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Earnings Growth
Companies with strongest year-over-year earnings growth